SCHEMBL21748018

SCHEMBL21748018

COc1cccc(OC)c1-n1c(NS(=O)(=O)C(C)C(OC)c2ncc(C)cn2)nnc1-c1cncc(C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18245716 1.00 APLNR (1.00) APLNR
SCHEMBL30727138 1.00 APLNR (1.00) APLNR
SCHEMBL18246471 1.00 APLNR (1.00) APLNR
SCHEMBL29219023 1.00 APLNR (1.00) APLNR
SCHEMBL18246776 1.00 APLNR (1.00) APLNR
SCHEMBL18246417 1.00 APLNR (1.00) APLNR
SCHEMBL18522943 0.96 APLNR (0.92) APLNR
SCHEMBL18246831 0.95 APLNR (1.00) APLNR
SCHEMBL18245539 0.95 APLNR (1.00) APLNR
SCHEMBL21748037 0.95 APLNR (1.00) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3300500-B9 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2021-01-13 EP claimed
EP-3300500-B1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-02-26 EP claimed
CN-117897157-A Apelin receptor modulators for the treatment of age-related muscle disorders 百爱及生物医药公司 2024-04-16 CN disclosed
EP-3300500-B9 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2021-01-13 EP disclosed
CN-108137545-B Triazole agonists of the APJ receptor 美国安进公司 2020-09-22 CN disclosed
EP-3300500-B1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-02-26 EP disclosed